Propranolol treatment of thyrotoxicosis
Karlberg, B.
Lakartidningen 67(50): 5917-5922
1970
ISSN/ISBN: 0023-7205 PMID: 4395268 Document Number: 27580
Document emailed within 1 workday
Related Documents
Felt, V. 1970: Block of adrenergic beta-receptors by propranolol in the treatment of thyrotoxicosis Review of Czechoslovak Medicine 16(3): 140-144Chapdelaine, A.; Coulombe, R.; LeLorier, J. 1976: The effects of propranolol, practolol, and placebo on the clinical manifestations of thyrotoxicosis International Journal of Clinical Pharmacology and Biopharmacy 14(4): 308-312
Zamrazil, V.; Felt, V.; Nĕmec, J.; Vána, S. 1972: Effects of trimepranol and propranolol on glucide and free fatty acid metabolism in thyrotoxicosis Casopis Lekaru Ceskych 111(14): 312-316
Felt, V.; Vána, S.; Zamrazil, V. 1971: Effect of adrenergic blockade by trimepranol and propranolol on protein iodine and the severity of thyrotoxicosis Casopis Lekaru Ceskych 110(25): 595-597
Vickers, P.; Garg, K.M.; Arya, R.; Godha, U.; Mathur, P.; Jain, S. 1990: The role of selective beta 1-blocker in the preoperative preparation of thyrotoxicosis: a comparative study with propranolol International Surgery 75(3): 179-183
Jaillon, P.; Hecklé, J.; Weissenburger, J.; Cheymol, G. 1980: Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs Journal of Pharmacology and Experimental Therapeutics 212(2): 347-353
McIntosh, D. 1976: Surgery in the treatment of thyrotoxicosis Journal of the Royal College of Surgeons of Edinburgh 21(4): 197-210
Murakami, E.; Shiosaka, S.; Tohyama, M. 1981: Does fluorescent analogue of propranolol, 9-amino-acridine-propranolol, binding sites really show the beta-adrenoreceptors? Cellular and Molecular Biology Including Cyto-Enzymology 27(2-3): 133-137
Frey, H. 1977: Drug treatment of thyrotoxicosis during pregnancy Ugeskrift for Laeger 139(3): 159-160
Fernández-Cruz, L. 1984: Radioiodine or surgery in the treatment of thyrotoxicosis Medicina Clinica 82(14): 637-638
Mardarowicz, G.; Lopatyński, J. 1987: Use of beta-adrenolytics in the treatment of thyrotoxicosis Polski Tygodnik Lekarski 42(36): 1099-1103
Papi, G. 2005: Current issues in the treatment of thyrotoxicosis Recenti Progressi in Medicina 96(11): 560-565
Albani, F.; Riva, R.; Baldrati, A.; Cortelli, P.; Perucca, E.; Procaccianti, G.; Baruzzi, A. 1984: Plasma concentrations of propranolol and 4-hydroxy-propranolol at steady-state in neurological patients: intersubject and intrasubject correlations with dose International Journal of Clinical Pharmacology Research 4(1): 19-23
Ongcharit, C.; Tungsanga, K. 1977: Propranolol and propranolol with thiazide in hypertensive Thai patients Journal of the Medical Association of Thailand 60(10): 465-469
Grosz, H.J. 1972: Successful treatment of a heroin addict with propranolol: implications for opiate addiction, treatment and research Journal of the Indiana State Medical Association 65(6): 505-509
Keren, G.; Lehr, V.; Boichis, H. 1985: Erythema nodosum related to propylthiouracil treatment for thyrotoxicosis Israel Journal of Medical Sciences 21(1): 62-63
Chiou, S.C.; Houng, H.S.; Li, K.L.; Ghang, T.C.; Lo, S.K.; Sun, R.H.; Huang, Y.Y.; Hsu, B.R.; Lin, J.D.; Hunang, B.Y. 1995: Outcome of Graves' thyrotoxicosis after antithyroid drug treatment Changgeng Yi Xue Za Zhi 18(4): 305-314
Pedro, T.; Martínez-Hervás, S.; Lorente, R.; Catalá, M.; Ortega, J.; Real, J.T.; Carmena, R. 2007: Difficult treatment of amiodarone-induced thyrotoxicosis: a case report Anales de Medicina Interna 24(11): 543-546
Sadykova, M.S. 1971: The state of the reproductive systems in women with thyrotoxicosis, before and after pathogenetic treatment Akusherstvo i Ginekologiia 47(7): 43-46
Bednár, J.; Nĕmec, J.; Soutorová, M.; Neradilová, M.; Pohunková, D.; Zamrazil, V.; Vána, S.; Havelka, J.; Röhling, S. 1979: Labelled amino acids in plasma of patients with thyrotoxicosis and thyroid cancer after radioiodine treatment Endocrinologia Experimentalis 13(1): 53-63